Sanofi’s Nuvaxovid Shows Superior Tolerability vs mNEXSPIKE in Head-to-Head Study

Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase...

April 21, 2026 | Tuesday | Reports
Nxera Pharma Secures Third R&D Milestone in Neurology Collaboration with AbbVie

This marks the third milestone achieved under the collaboration and reflects the steady progress of the pipeline Under the terms of the agreement, Nxe...

April 21, 2026 | Tuesday | News
Oncodesign Services Expands Radionuclide Access Through Extended Collaboration with GIP ARRONAX

Oncodesign Services has extended its collaboration with GIP ARRONAX to secure access to astatine-211 (At-211) as well as other radionuclides used in targ...

April 20, 2026 | Monday | News
Repligen Opens New Training & Innovation Center in the Netherlands to Strengthen Global Bioprocessing Support

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new ...

April 20, 2026 | Monday | News
MiNK’s agenT-797 Combination Delivers 77% Disease Control Rate in Gastroesophageal Cancer Study

First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients and l...

April 20, 2026 | Monday | News
Evaxion’s EVX-01 Shows Record 86% Immune Response Rate in Phase 2 Personalized Cancer Vaccine Study

New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune response...

April 20, 2026 | Monday | News
PacBio and Covaris Unveil Integrated Workflow to Unlock HiFi Sequencing from FFPE Tumor Samples

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample...

April 17, 2026 | Friday | News
Myriad Genetics Secures Japan Approval for MyChoice® as Companion Diagnostic in Prostate Cancer

- Myriad Genetics Inc.,  a leader in molecular diagnostic testing and precision medicine,announced that Japan’s Ministry of Health, Labour and...

April 16, 2026 | Thursday | News
PannTheraPi Advances PTI5803 into Phase 2a for Rare Epilepsy, Secures European Patent and Appoints New CSO

Regulatory submission filed to initiate a Phase 2a trial of its drug candidate, PTI5803 in patients with focal cortical dysplasia (FCD), a rare and sev...

April 15, 2026 | Wednesday | News
Thermo Fisher Scientific Expands PPD™ Clinical Research Capabilities Through Strategic Data Collaboration with HealthVerity

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD...

April 15, 2026 | Wednesday | News
EU Expands Dupixent Approval to Young Children with Chronic Spontaneous Urticaria

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy ...

April 14, 2026 | Tuesday | News
GenScript and Mimulus Partner to Industrialize DNA Data Storage for the AI Era

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Co...

April 13, 2026 | Monday | News
Virica and FUJIFILM Biosciences Collaborate to Boost AAV Manufacturing Efficiency

Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access an...

April 10, 2026 | Friday | News
Ofichem Consolidates Brands to Deliver a Fully Integrated CDMO Model

One Ofichem. One voice. A more connected approach to pharmaceutical partnerships. Ofichem has brought its brands - Ofichem BV, Ofipharma, Ofimedicine, L...

April 10, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close